AntineoplasticsDrug resistance and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1953卷 / 1期

关键词：

D O I：

10.1007/s40278-023-37480-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：45 / 45

相关论文

共 50 条

[41] Diazoxide/insulinInsulin resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 190 - 190
[42] AntineoplasticsAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1968 (1) : 37 - 37
[43] AntineoplasticsAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 65 - 65
[44] AntineoplasticsDevelopment of drug resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 54 - 54
[45] Gefitinib/osimertinibDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 219 - 219
[46] Multiple drugsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1930 (1) : 370 - 370
[47] Antibacterials/antitubercularsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 42 - 42
[48] Afatinib/osimertinibAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 24 - 24
[49] AntibacterialsAquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 41 - 41
[50] AntineoplasticsDevelopment of drug resistance and lack of efficacy: case report
Reactions Weekly, 2021, 1843 (1) : 43 - 43

← 1 2 3 4 5 →